Target Audience

This activity was developed for pharmacists and other healthcare professionals practicing in a managed care environment.

Learning Objectives

Upon completion of this activity, the participant will be able to:

• Explain the impact of key data from ASCO 2010 on payers and providers regarding chronic myelogenous leukemia (CML)
• Assess potential clinical, business, and regulatory changes in CML
• Discuss patient-centered, value-based care for CML

• Commercial Support Acknowledgment
  This activity is supported by an educational grant from Novartis Pharmaceuticals.

Instructions for Credit

There is no fee for this activity. After reading this CME/CE activity in its entirety, participants must complete the posttest and evaluation. The posttest and evaluation can be completed online at www.mlicme.org/p10057.html. Upon completion of the evaluation and scoring 70% or better on the posttest, you will immediately receive your certificate online. If you do not achieve a score of 70% or better on the posttest, you will be asked to take it again. Please retain a copy of the certificate for your records.

For questions regarding the accreditation of this activity, please contact Medical Learning Institute, Inc., at 609-333-1693 or cgusack@mlicme.org.

Pharmacists Designation

Medical Learning Institute, Inc., is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Completion of this activity provides for 1.0 contact hour (0.1 CEU) of continuing education credit. The universal activity number for this activity is 0468-9999-10-045-H01-P.

Disclosures

Before the activity, all faculty will disclose the existence of any financial interest and/or relationship(s) they might have with the manufacturer(s) of any commercial product(s) to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speaker’s bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. 

The associates of Medical Learning Institute, Inc., and Center of Excellence Media, LLC, have no financial relationships to disclose.

Michael Mauro, MD, has received research grants from, and is a consultant to, Bristol-Myers Squibb and Novartis Oncology.

Gary M. Owens, MD, is a consultant to Auxilium, Genzyme, GlaxoSmithKline, and Eli Lilly and Company.

Disclaimer

The information provided in this CME/CE activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. Trade names used in this supplement are for the learner’s reference only. No promotion of or bias toward any product should be inferred.

Estimated time to complete activity: 1 hour

Initial Release Date: September 15, 2010.

Expiration Date: September 15, 2011.